期刊文献+

匹伐他汀钙治疗62例老年高胆固醇血症的临床观察 被引量:14

Clinical observation of pitavastatin calcium on treatment of 62 elderly hypercholesterolemic patients
下载PDF
导出
摘要 目的观察匹伐他汀钙对老年高胆固醇血症患者降脂治疗的有效性和安全性。方法 62例老年高胆固醇血症患者每晚睡前口服匹伐他汀钙,剂量4 mg/d,共6周,观察用药前后总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、肌酸磷酸激酶(CPK)水平变化,以及肝、肾功能情况。结果治疗3周后TC、LDL-C水平均较治疗前显著下降(P<0.01),治疗6周后HDL-C水平较治疗前显著上升(P<0.01),TG水平明显下降(P<0.05),总有效率90.97%。治疗6周后肝、肾功能及CPK无明显变化(P>0.05)。结论匹伐他汀钙对老年高胆固醇血症患者降脂治疗有效且安全,值得临床推广。 Objective To observe the efficacy and safety of pitavastatin calcium in elderly patients with hypercholesterolemia.Methods 62 cases of elderly patients with hypercholesterolemia were gave pitavastatin calcium 4 mg before bedtime for 6 weeks.Before and after treatment,The levels of total cholesterol(TC),triglyceride(TG),high density lipoprotein(HDL-C),low density lipoprotein(LDL-C),creatine kinase(CPK) were observed and the liver and kidney function were detected.Results After 3 weeks of treatment,the levels of TC,LDL-C were significantly decreased than before treatment(P0.01).After 6 weeks of treatment,the level of HDL-C was increased significantly(P0.01),but the level of TG was decreased significantly(P0.05),total effective rate was 90.97%.After 6 weeks of treatment,the level of CPK,the liver and kidney function had no significant changes(P0.05).Conclusion Pitavastatin calcium is effective and safe in elderly patients with hypercholesterolemia.
作者 黄华
出处 《重庆医学》 CAS CSCD 北大核心 2011年第5期469-470,共2页 Chongqing medicine
关键词 高胆固醇血症 治疗效果 匹伐他汀钙 hypercholesterolemia treatment outcome pitavastatin calcium
  • 相关文献

参考文献6

二级参考文献53

  • 1于波.冠心病的调脂治疗[J].医师进修杂志,2004,27(10):1-3. 被引量:9
  • 2金平欣,王建双.阿托伐他汀治疗冠心病血脂异常疗效观察[J].中华当代医学,2005,3(3):51-52. 被引量:1
  • 3李建勇,胡大一,史旭波,仝其广.不同剂量阿托伐他汀对冠心病患者的疗效和安全性多中心研究[J].中华心血管病杂志,2005,33(12):1085-1087. 被引量:21
  • 4范维琥.他汀类药物及其非降脂作用疗效评价[J].临床新视点,2002,(1):9-9.
  • 5宁育.心衰治疗新策略[J].中国医学论坛报,2002,28(41):30-30.
  • 6诸骏仁.调脂治疗的趋势[J].临床新视点,2002,(1):1-2.
  • 7[1]Shepherd J,Blauw GJ,Murphy MB,et al.Pravastatin in elderly individuals at risk of vascular disease(PROSPER):A randomised controlled trial[J].Lancet,2002,360(9346):1623-1630.
  • 8[2]Cannon CP,Braunwald E,McCabe CH,et al.Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators.Intensive versus moderate lipid lowering with statins after acute coronary syndromes[J].N EnglJ Med,2004,350(15):1495-1504.
  • 9[3]Bolego C,Poll A,Cignarella A,et al.Novel statins:Pharmacological and clinical results[J].Cardiovase Drugs Ther,2002,16(3),251-257.
  • 10[4]Saito Y,Yamada N,Teramoto T.et al.Clinical efficacv of pitavastatin,a new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor,in patients with hyperlipidemia.Dose finding study using the double-blind,three-group parallel comparison[J].Arzneimittelforschung,2002,52(4):251-255.

共引文献108

同被引文献88

  • 1程翔,廖玉华.炎症与动脉粥样硬化[J].中华心血管病杂志,2004,32(5):475-477. 被引量:87
  • 2《中国糖尿病防治指南》(试行本)(节选)[J].中国慢性病预防与控制,2004,12(6):283-285. 被引量:308
  • 3陈图刚,陈君柱.辛伐他汀对高胆固醇血症患者动脉弹性的影响[J].中国综合临床,2006,22(11):969-970. 被引量:2
  • 4中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5233
  • 5中华人民共和国卫生部.药物临床研究指导原则[M].北京:人民卫生出版社,1998.86-88.
  • 6Baker W L, Datta R. Pitavastatin: a new 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibitor for the treat- ment of hyperlipidemia [ J ]. Adv Ther, 2011,28 ( 1 ) : 13- 27.
  • 7Panchal H J, Suhagia B N, Patel M M, et al. Estimation of pitavastatin calcium in tablet dosage ibrms by column liquid chromatography and ultraviolet spectrophotometry [J].J AOAC Int, 2009,92(1):158-164.
  • 8Suzuki M, Iwasaki H, Fujikawa Y, et al. Synthesis and biological evaluations of quinoline-based HMG-CoA re- ductase inhibitors [ J ]. Bioorg Med Chem, 2001,9 ( 10 ) : 2727 -2743.
  • 9Saito Y. Critical appraisal of the role of pitavastatin in trea- ting dyslipidemias and achieving lipid goals [ J ]- Vase Health Risk Manag, 2009,5:921-936.
  • 10Park S, Kang H J, Rim S J, et al. A randomized, open- label study to evaluate the efficacy and safety of pitavasta- tin compared with simvastatin in Korean patients with hy- percholesterolemia[ J ]. Clin Ther, 2005,27 ( 7 ) : 1074- 1082.

引证文献14

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部